Office of Technology Assessment. Development of medical technology: Opportunities for assessment. Washington, DC: Office of Technology Assessment; 1976.
Burls, A, Caron, L, Langavant, GC, et al.
Tackling ethical issues in health technology assessment: A proposed framework. Int J Technol Assess Health Care. 2011;27:230–237.
Droste, S, Dintsios, CM, Gerber, A, Rüther, A. Integrating ethical issues in HTAs: More methods than applications? In: HTAi 7th Annual Meeting Dublin 2010. Maximizing the value of HTA. Book of Abstracts; Dublin: 2010;M5-02:169.
Hofmann, B. Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care. 2005;21:312–318.
Saarni, S, Braunack-Mayer, A, Hofmann, B, van der Wilt, GJ. Different methods for ethical analysis in health technology assessment: An empirical study. Int J Technol Assess Health Care. 2011;27:305–312.
Saarni, SI, Hofmann, B, Lampe, K, et al.
Ethical analysis to improve decision-making on health technologies. Bull World Health Organ. 2008;86:617–623.
DeJean, D, Giacomini, M, Schwartz, L, Miller, FA. Ethics in Canadian health technology assessment: A descriptive review. Int J Technol Assess Health Care. 2009;25:463–469.
Droste, S, Gerhardus, A, Kollek, R. [Methods for the assessment of ethical aspects and moral concepts in society in short HTA reports an international survey]. Niebüll: Medicombooks; 2003.
Hofmann, B. Why ethics should be part of health technology assessment. Int J Technol Assess Health Care. 2008;24:423–429.
Lehoux, P, Williams-Jones, B. Mapping the integration of social and ethical issues in health technology assessment. Int J Technol Assess Health Care. 2007;23:9–16.
Ten Have, H. Ethical perspectives on health technology assessment. Int J Technol Assess Health Care. 2004;20:71–76.
Hofmann, B. On value-judgements and ethics in health technology assessment. Poiesis Prax. 2005;3:277–295.
Brinch, B, Husebekk, A, Funderud, S, Lyngstadaas, A. Therapeutic use of haematopoietic stem cells from cord blood. Oslo: SMM-rapport No. 4/2003.
Droste, S, Herrmann-Frank, A, Scheibler, F, Krones, T. Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: A systematic literature review. BMC Med Ethics. 2011;12:6.
UK National Screening Committee [Internet]. London: Criteria for appraising the viability, effectiveness and appropriateness of a screening programme [cited 2012 Aug 12]. http://www.screening.nhs.uk/criteria (Accessed, July 1, 2012).
Etikk i vurdering av helsetiltak [Ethics in Health Technology Assessments (HTA)] Oslo: Norwegian Knowledge Centre for the Health Services; 2008.
Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York: CRD, University of York; 2009.
McCullough, LB, Coverdale, JH, Chervenak, FA. Constructing a systematic review for argument-based clinical ethics literature: The example of concealed medications. J Med Philos. 2007;32:65–76.
Sofaer, N, Strech, D. The need for systematic reviews of reasons. Bioethics. 2012;26:315–328.
Strech, D, Sofaer, N. How to write a systematic review of reasons. J Med Ethics. 2012;38:121–126.
Hannes, K, Lockwood, C, Pearson, A. A comparative analysis of three online appraisal instruments’ ability to assess validity in qualitative research. Qual Health Res. 2010;20:1736–1743.
First things first: Priority setting for Health Technology Assessment [Dissertation]. Leiden: De Bink BV; 2000.
Acht nieuwe geneesmiddelen toegelaten tot het ziekenfondspakket (12 April 2000, nr. 38). Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport; 2000.
Daniels, N, Sabin, J. Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff. 1997;26:303–350.